American Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-51,745
Closed -$7.57M 82
2016
Q4
$7.57M Sell
51,745
-1,240
-2% -$187K 0.59% 44
2016
Q3
$8.84M Buy
+52,985
New +$8.96M 0.68% 41
2016
Q2
Sell
-55,700
Closed -$8.35M 111
2016
Q1
$8.35M Buy
55,700
+807
+1% +$120K 0.73% 41
2015
Q4
$8.91M Buy
+54,893
New +$8.63M 0.79% 38

Other funds holding AMGN

American Capital Management's AMGN Position: Q1 2017 in Review

American Capital Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 51,745 shares — an estimated $7.57M sold.

American Capital Management first reported a position in AMGN in Q4 2015 and held it in 4 quarters. The position peaked at $8.91M in Q4 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • American Capital Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • American Capital Management sold 51,745 Amgen shares in Q1 2017, an estimated $7.57M.
  • American Capital Management first reported a position in Amgen in Q4 2015 and held it in 4 quarters.
  • American Capital Management's Amgen position peaked at $8.91M in Q4 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on American Capital Management's 13F filing for Q1 2017, filed 24 Apr 2017.